The Phase 3, double-blind, placebo-controlled FIBRONEER-IPF and FIBRONEER-ILD trials evaluated nerandomilast in patients with IPF and progressive pulmonary fibrosis (PPF), respectively. Stable treatment with an oral antifibrotic (e.g., nintedanib or pirfenidone) was allowed to continue
It is not a dosing, administration, or treatment protocol and does not constitute medical, clinical, veterinary guidance or treatment advice.
Figure 2 CC chemokines including CCL2, CCL3, CCL4, CCL5, CCL7, CCL13, CCL14, CCL16, CCL18, CCL19, CCL20, CCL21, and CCL25 are abnormally expressed in plasma and synovia in RA
All of these GLP-1 effects (Figure 2) are potentially beneficial for patients with T2D, and have been sought exploited clinically with the development of GLP-1R agonists
Wegovy Pill might work better if you: Feel uncomfortable with needles or self-injection Travel often and prefer skipping refrigeration Prefer building a daily morning habit Can stick to the empty-stomach and 30-minute wait requirement The weekly injection might be a better match if you: Would rather dose once a week than every day Want more flexibility around meals and timing Find it hard to remember a daily medication Prefer personalized dosing through a program like GLP-1 ID Theres no single right answer